Enanta Pharmaceuticals
ENTA
ENTA
183 hedge funds and large institutions have $1.19B invested in Enanta Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 74 increasing their positions, 54 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
7% less funds holding
Funds holding: 197 → 183 (-14)
16% less capital invested
Capital invested by funds: $1.42B → $1.19B (-$228M)
35% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 37
Holders
183
Holding in Top 10
3
Calls
$4.55M
Puts
$4.43M
Top Buyers
| 1 | +$44M | |
| 2 | +$10.8M | |
| 3 | +$7.97M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.02M |
| 5 |
Citigroup
New York
|
+$4.42M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$16.9M | |
| 3 | -$12.8M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$7.91M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$7.06M |